Cortria Corporation Appoints Dennis H. Giesing, Ph.D., Former Worldwide Head of Lead Optimization at Aventis Pharmaceuticals, Inc. (AVE), as Head of Research and Development
12/9/2008 9:33:51 AM
BOSTON--(BUSINESS WIRE)--Cortria Corporation today announced the appointment of Dennis H. Giesing, Ph.D., as Head of Research and Development. Dr. Giesing brings over thirty years of experience in pharmaceutical drug development, most recently at Aventis Pharmaceuticals where he had worldwide responsibility for the Aventis R&D product pipeline from late discovery through early clinical development.
comments powered by